Ellen Rosenberg - Dec 31, 2021 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Dec 31, 2021
Transactions value $
-$266,214
Form type
4
Date filed
1/4/2022, 08:04 PM
Next filing
Jan 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Tax liability -$110K -9.48K -3.93% $11.55 232K Dec 31, 2021 Direct
transaction FOLD Common Stock Tax liability -$76.1K -6.59K -2.84% $11.55 225K Jan 2, 2022 Direct
transaction FOLD Common Stock Tax liability -$36K -2.97K -1.32% $12.11 222K Jan 3, 2022 Direct
transaction FOLD Common Stock Award +73.1K +32.92% 295K Jan 3, 2022 Direct F1, F2
transaction FOLD Common Stock Tax liability -$44.6K -3.58K -1.21% $12.48 292K Jan 4, 2022 Direct
holding FOLD Common Stock 15K Dec 31, 2021 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +134K $0.00 134K Jan 3, 2022 Common Stock 134K $12.11 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
F2 The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023.
F3 These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.